Abstract
Tisotumab vedotin is a tissue factor-directed antibody-drug conjugate developed for treatment of recurrent or metastatic cervical cancer (r/mCC). In t......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
